FDA-cleared alexandrite, Nd:YAG, and picosecond laser platforms designed for dermatologists, plastic surgeons, and medical spa practitioners. 35 years of clinical laser development. 25,000+ systems installed across 130 countries. ISO 13485 certified manufacturing.
Each platform is designed for specific clinical indications, backed by published efficacy data and regulatory clearances. Wavelength, pulse duration, and spot size parameters are optimized for their intended dermatological applications.
Dual-wavelength alexandrite (755nm) and Nd:YAG (1064nm) with Skintel melanin reader. FDA-cleared for hair reduction, pigmented lesions, and vascular treatments across Fitzpatrick skin types I-VI.
755nm alexandrite picosecond laser with PressureWave technology. The first FDA-cleared picosecond aesthetic laser. Indicated for tattoo removal (all ink colors), benign pigmented lesions, and skin revitalization.
High-power 810nm diode laser engineered specifically for hair reduction. Large spot size (23x38mm) for rapid coverage of treatment areas. Skintel melanin reader compatible for objective fluence selection.
Each clinical indication below is supported by peer-reviewed published data. We reference specific study outcomes rather than anecdotal claims. Actual results depend on patient characteristics, treatment parameters, and operator technique.
Long-pulse alexandrite and diode wavelengths targeting follicular melanin. Published 12-month follow-up data showing 80-90% reduction in terminal hair count.
PicoSure picosecond technology fragments ink particles more efficiently than nanosecond systems. Published clearance rates for multi-colored tattoos across 6-10 sessions.
PicoSure Focus Lens Array creates controlled zones of epidermal disruption triggering collagen and elastin remodeling. Published improvement in skin texture and tone.
Selective photothermolysis of melanin-containing cells using wavelength-specific absorption. Effective for lentigines, cafe-au-lait macules, and dermal melanocytosis.
1064nm Nd:YAG targets hemoglobin in superficial and deep vascular structures. Applications include telangiectasia, spider veins, and select hemangiomas.
1060nm diode laser hyperthermic destruction of subcutaneous adipocytes. Non-invasive alternative to liposuction for localized fat reduction in cleared treatment zones.
Fractional delivery of picosecond energy creates microscopic treatment zones that trigger dermal remodeling. Published improvement in atrophic acne scarring at 3-month follow-up.
Controlled dermal heating triggers neocollagenesis and elastin fiber remodeling. Gradual improvement in skin laxity measured over 3-6 months post-treatment.
Each claim below is substantiated by regulatory filings, published clinical data, or auditable quality system records. We disclose the evidence basis so you can evaluate independently.
Cynosure laser systems deliver wavelength-specific energy through factory-calibrated alexandrite (755nm), Nd:YAG (1064nm), and diode (810nm) sources. The Elite iQ integrates the Skintel melanin reader to adjust fluence parameters based on objective skin melanin measurements, reducing operator-dependent variables across Fitzpatrick skin types I through VI. Spot sizes range from 2mm to 24mm to match beam geometry to treatment area requirements.
Every Cynosure system meets FDA 21 CFR 1040, IEC 60601-1, and IEC 60825-1 requirements. The Elite iQ and PicoSure Pro hold active FDA 510(k) clearances for specified dermatological indications. European distribution operates under CE MDR compliance. ISO 13485 quality management with annual notified body surveillance audits. Clinics using Cynosure systems operate with documented clearances that satisfy facility inspectors and malpractice carriers.
Cynosure platforms are referenced in over 200 peer-reviewed publications in PubMed and Scopus. PicoSure alone has 80+ published clinical studies covering tattoo removal, skin revitalization, and pigmented lesion treatment. Elite iQ has published long-term hair reduction data at 12 and 24-month follow-up intervals. Practitioners referencing Cynosure can cite specific published studies rather than manufacturer marketing materials alone.
Feedback from verified system operators. Names withheld per data protection requirements; practice type and region confirmed.
"We evaluated the Elite iQ against two competing dual-wavelength platforms. The Skintel melanin reader integration was the differentiator — it removed the subjectivity from fluence selection for our diverse patient population. After 14 months and approximately 2,800 treatments, our adverse event rate dropped from 3.2% on our previous system to under 0.8%."
"PicoSure Pro handles multi-colored tattoos that our previous nanosecond Q-switched system could not clear effectively — particularly greens and blues. Average session count to near-complete clearance dropped from 12-15 to 6-8 in our tracked cohort. The ROI calculation becomes straightforward when patients see faster results and refer others."
"The Vectus large spot size — 23 by 38 millimeters — reduced our full-leg hair reduction treatment time from 45 minutes to approximately 20 minutes per session. That efficiency gain allows us to schedule three additional patients per day per treatment room. The diode technology also runs cooler than our previous IPL system."
Schedule a clinical consultation with our medical applications team. We provide objective guidance based on your practice demographics, treatment mix, and growth objectives. No obligation — just evidence-based recommendations.